Does TOFACITINIB Cause Facial paralysis? 59 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Facial paralysis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.0% of all adverse event reports for TOFACITINIB.
59
Reports of Facial paralysis with TOFACITINIB
0.0%
of all TOFACITINIB reports
1
Deaths
22
Hospitalizations
How Dangerous Is Facial paralysis From TOFACITINIB?
Of the 59 reports, 1 (1.7%) resulted in death, 22 (37.3%) required hospitalization, and 2 (3.4%) were considered life-threatening.
Is Facial paralysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Facial paralysis?
ADALIMUMAB (382)
ONABOTULINUMTOXINA (305)
METHOTREXATE (304)
NIVOLUMAB (171)
ETANERCEPT (169)
RITUXIMAB (151)
SECUKINUMAB (140)
PREDNISONE (139)
ASPIRIN (127)
FINGOLIMOD (121)
Which TOFACITINIB Alternatives Have Lower Facial paralysis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN